Zhongyu Yuan

No ORCID on file · 1 paper in corpus
observational 2025
BMC cancer ·doi:10.1186/s12885-025-13791-z

BACKGROUND: The plasma concentration of endoxifen, the active metabolite of tamoxifen, might be affected by different CYP2D6 genotypes in patients with breast cancer, but solid evidence is still lacking in Asian patients. This prospective s…